Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly and Company Investors: Company Investigated by the Portnoy Law Firm
05:25pm, Thursday, 21'st Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
One of the Best Stocks to Buy Now?
09:30am, Wednesday, 20'th Aug 2025
Eli Lilly (LLY -1.36%) stock investors need to be aware of these details before making a decision to buy or sell the stock.
What's Going on With Eli Lilly Stock?
09:23am, Wednesday, 20'th Aug 2025
Eli Lilly (LLY -1.36%) is one of my best stocks to buy in 2025.
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
09:00am, Wednesday, 20'th Aug 2025
INDIANAPOLIS , Aug. 20, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Anne White, executive vice president and president, Lilly Neuroscience, will be retiring from Li
Pharmaceuticals Industry Analysis: Eli Lilly Tops My Tier Two
04:16am, Wednesday, 20'th Aug 2025
I invest for long-term total return, focusing on high-quality, dividend-paying industry leaders with strong financials and consistent performance. Despite current headwinds like tariffs and patent exp
2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist
11:24am, Monday, 18'th Aug 2025
Key Points in This Article: Dividend growth investing offers stable income and capital appreciation through compounding returns.
Lilly Stock Down 5% This Month: Should You Buy the Dip?
10:15am, Monday, 18'th Aug 2025
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill orforglipron disappointed.
Eli Lilly: A Textbook Insider Buying Play
07:43am, Monday, 18'th Aug 2025
I initiate my coverage on Eli Lilly with a 'Buy' after an eventful Q2 earnings season. The stock looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbou
This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors
07:15am, Sunday, 17'th Aug 2025
After crushing the market over the past few years, Eli Lilly (LLY 2.73%) is finally feeling the effects of gravity. The company has faced a pair of setbacks this year.
3 Fantastic Growth Stocks to Buy in August
06:42am, Sunday, 17'th Aug 2025
We're well into the home stretch of 2025. August is more than halfway over.
Eli Lilly: Don't Bet Against This Biotech Powerhouse
01:30am, Sunday, 17'th Aug 2025
Eli Lilly's recent 20% pullback is a buy-the-dip opportunity, as the market overreacted to mixed Orforglipron results. Blockbuster drugs Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 9
Jim Cramer names his top 5 stock picks, dismisses dot-com style meltdown
02:51pm, Saturday, 16'th Aug 2025
Former hedge fund manager and CNBC's Mad Money host Jim Cramer has dismissed fears that the stock market might be heading for another Dot-com style meltdown.
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.
08:45am, Saturday, 16'th Aug 2025
Wall Street loves a dominant player, and Eli Lilly (LLY 2.73%) looks unstoppable with its obesity blockbusters printing money faster than the Fed. But here's what the bulls aren't telling you: The com
What Moved Markets This Week
07:18am, Saturday, 16'th Aug 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst
01:54pm, Friday, 15'th Aug 2025
On Thursday, Eli Lilly and Co. LLY said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom.
